US Patent Issued to QINGDAO CONSON PHARMACEUTICAL, MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO on Jan. 27 for "Beta-glucan composition and use therefor" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,373, issued on Jan. 27, was assigned to QINGDAO CONSON PHARMACEUTICAL Co. LTD. (Shandong, China) and MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO Co. LTD. (Qingdao, China).

"Beta-glucan composition and use therefor" was invented by Guangli Yu (Shandong, China), Youjing Lv (Shandong, China), Xianjun Qu (Shandong, China), Chenyang Zhao (Shandong, China), Jiejie Hao (Shandong, China), Quancai Li (Shandong, China), Xia Zhao (Shandong, China), Ting Hu (Shandong, China) and Huashi Guan (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Beta-glucan composition and use thereof. Specifically provided are uses of the Beta-glucan composition ...